HomepageEarnings Events Newsdesk 13 hours ago Rollins, Inc (ROL) Q1 2026 Earnings Results Rollins, Inc (NYSE: ROL) Q1 2026 Earnings Release Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Showing Sustained Glucocorticoid Dose Reductions While Maintaining Androgen Control in Adults with Classic Congenital Adrenal Hyperplasia » « CSX Corporation (CSX) Q1 2026 Earnings Results Newsdesk:
